Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 24Unknown 8Terminated 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 1Pruritus 1Breast Neoplasms 1

Interventions

peppermint oil 1fosaprepitant 1almond oil 1Standard of Care 1Palonosetron 1Olanzapine 1Growth Differentiation Factor 15 1Fecal Microbiota Transplantation 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Vomiting × Aprepitant × Clear all
NCT05841849 2023-05-03

Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Not yet recruiting
1,028 enrolled
Breast

Breast Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡